Journal
EMERGING TOPICS IN LIFE SCIENCES
Volume 5, Issue 6, Pages 815-827Publisher
PORTLAND PRESS LTD
DOI: 10.1042/ETLS20210213
Keywords
-
Categories
Funding
- C3.ai Digital Transformation Institute COVID-19 award
- NIH [NIAID P01-AI152999]
- National Library of Medicine Training Program in Biomedical Informatics and Data Science [T15LM007093]
Ask authors/readers for more resources
Machine learning methods have shown promising results in disease prediction using gut microbiome data, particularly for liver cirrhosis and irritable bowel disease. However, challenges still exist in predicting other illnesses. Future research should focus on overcoming computational challenges and considering overlooked biological components in this area.
Associations between the human gut microbiome and expression of host illness have been noted in a variety of conditions ranging from gastrointestinal dysfunctions to neurological deficits. Machine learning (ML) methods have generated promising results for disease prediction from gut metagenomic information for diseases including liver cirrhosis and irritable bowel disease, but have lacked efficacy when predicting other illnesses. Here, we review current ML methods designed for disease classification from microbiome data. We highlight the computational challenges these methods have effectively overcome and discuss the biological components that have been overlooked to offer perspectives on future work in this area.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available